Mucosal Vaccines, Adjuvants & Delivery

25-27 September 2013, Eigtveds Pakhus, Copenhagen, Denmark

  • Increase font size
  • Default font size
  • Decrease font size

Day One

Final Conference Programme | Wednesday 25th September

08.00 onwards
Registration

09.00-09.15
Welcome to Copenhagen & Opening Remarks
Peter Andersen (Statens Serum Institut, Copenhagen, Denmark)

SESSION 1:
OPENING PLENARY SESSION

Moderator: Peter Andersen (Statens Serum Institut, Copenhagen, Denmark)

09.15-09.45
‘Mucosal immunity by vaccination: Opportunities and challenges’
Ali Harandi (University of Gothenburg, Gothenburg, Sweden)

09.45-10.15
‘Strategies for achieving effective mucosal immunization of children living in developing countries’
Richard Walker (PATH, Washington DC, USA)

10.15-10.45
‘A nutritive immune-enhancing delivery system for mucosal and systemic vaccinations’
Michael Vajdy (EpitoGenesis Inc., Walnut Creek, California, USA)

10.45-11.05
Coffee Break & Poster Set-Up

SESSION 2:
PLENARY II

Moderator: Cecil Czerkinsky (University of Gothenburg, Gothenburg, Sweden)

11.05-11.35
'Introduction to mucosal immune defence'
Per Brandtzaeg (University of Oslo, Oslo, Norway)

11.35-12.05
‘T cells and mucosal immunity’
Shabaana A. Khader (Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, USA)

12.05-12.35
‘Th17 cells: beneficial and pathogenic roles in the immune system’
Birgitta Stockinger (MRC National Institute for Medical Research, London, UK)

12.35-13.05
‘From mouse to man – immune correlates’
Robin Shattock (Imperial College London, London, UK)

13.05-14.00
Lunch Break & Posters

SESSION 3:
VACCINES & VACCINATION

Moderator: John Clements (Tulane University, New Orleans, Louisiana, USA)

14.00-14.25
‘Novel mucosal adjuvant strategies for oral vaccination’
Ed Lavelle (Trinity College Dublin, Dublin, Ireland)

14.25-14.50
‘Vaccination against the mucosal pathogen Chlamydia trachomatis
Frank R. Follmann (States Serum Institut, Copenhagen, Denmark)

14.50-15.10
‘Challenges of oral vaccination in the young pig: What can we learn?’
Eric Cox (Ghent University, Ghent, Belgium)

15.10-15.30
‘Self-adjuvanting mucosal Group A Streptococcus (GAS) vaccine candidate’
Istvan Toth, M. Zaman, M. Skwarczynski, M.R. Batzloff and M.F. Good (The University of Queensland, Brisbane, Quennsland, Australia)

15.30-15.50
‘BLP-based mucosal vaccines: Development of the intranasal RSV F subunit vaccine SynGEM®’
Maarten van Roosmalen, Kees Leenhouts, Bert Jan Haijema, Ivy Widjaja and Alan Rigter (Mucosis BV, Groningen, The Netherlands)

15.50-16.10
‘Early host-virus interactions in response to low dose SIV challenge in the macaque rectal mucosa: Implications for effective vaccine prevention of sexually transmitted AIDS’
Michael Murphy-Corb (University of Pittsburgh, Pittsburgh, Pennsylvania, USA)

16.10-16.30
Tea Break & Posters

SESSION 4:
ENTERICS & SUBLINGUAL VACCINATION

Moderator: Ali Harandi (University of Gothenburg, Gothenburg, Sweden)

16.30-16.55
‘Excellent safety and immunogenicity of an oral, inactivated, multivalent whole cell-B subunit ETEC vaccine tested with and without dmLT adjuvant in a placebo-controlled Phase I study’
A. Lundgren, J. Adamsson, L. Bourgeois, N. Carlin, J. Clements, B. Gustafsson, M. Hartford, J. Holmgren, J. Kaim, S. Koster, M. Lofstrand, M. Petzold, J. Tobias, R. Walker, G. Wiklund and A.-M. Svennerholm (Gothenburg University, Gothenburg, Sweden)

16.55-17.20
‘Sublingual vaccination: Preclinical and early stage clinical development’
Cecil Czerkinsky (University of Gothenburg, Gothenburg, Sweden)

17.20-17.45
‘Thermoresponsive gel formation for sublingual immunization’
Dexiang Chen (PATH, Seattle, Washington, USA)

17.45-18.05
‘Salivary IgA as a non-invasive readout for intestinal immune response against experimental enterotoxigenic Escherchia coli (ETEC) infection’
Audun Aase, Merete Bolstad, Halvor Sommerfelt and Per Brandtzaeg (Norwegian Institute of Public Health, Oslo, Norway)

18.05
MUCOVAD 2013 Welcome Reception
Sponsored by Statens Serum Institut, Copenhagen, Denmark

 

MUCOVAD 2013 Delegates

Login details will be supplied after you have registered for the event.


MUCOVAD 2013 Sponsors

  • Retroscreen Virology
  • Current Drug Delivery
  • Nature Gene Therapy
  • Mucosis
  • Immune Solutions
  • Univac
  • DNA Vaccine
  • Sanofi Pasteur
  • PATH
  • Drug Delivery Letters
  • Inovio Pharmaceuticals
  • Aldevron
  • Eurocine Vaccines
  • Izon
  • Pevion Vaccines
  • Biovaxx

MUCOVAD 2013 Downloads

MUCOVAD 2013 Leaflet

MUCOVAD 2013 Mailing List

Name
E-mail Address
What is 1+4-2?